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1. Introduction
Neuroblastoma (NB) is the most common extra-cranial tumor of childhood with more than
600 new cases per year in the United States. The clinical presentation is heterogeneous and
dependent on age at diagnosis, staging, histology, and alterations such as MYCN amplification
and chromosome 1p loss or 17q gain. High-risk patients with evidence of metastases have an
overall survival rate of less than 40% despite intensive multimodality treatment. This high‐
lights the urgent need for new therapeutic intervention strategies. However due to NB
characteristic molecular features, in about 10% of patients with metastases, tumors disappear
by apoptosis [1].
In the search of new anticancer agents with increased chemotherapeutic spectrum, and lower
toxicity, new substances based on metals have shown initial promising results. Casiopeínas®
(Cas) are a family of compounds with a central Cu2+ core atom and an amino acid acidates or
α, β-diketonates to seem give them tumor specificity [2]. To date, their action mechanisms are
still not completely understood. A possible mechanism may be envisaged however, since it
has been described that metals such as Copper and some complexes of them, participate in
redox reactions that may generate reactive oxygen species (ROS) including Hydrogen peroxide
(H2O2), hydroxyl radical (HO●) and superoxide (O2-●) [3] that are probably the main factors,
leading to apoptosis in cells exposed to these anti-tumor compounds [4-6]
Programmed cell death is an important process for the regulation of different pathways such
as cellular homeostasis, embryonic development or regulation of the immune system [7-9].
© 2013 Hernández-Lemus et al.; licensee InTech. This is an open access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Apoptosis, a form of programmed cell death, is a highly cotrolled process which includes
several well-characterized morphological changes, like membrane blebbing and cell shrink‐
age, chromatic condensation and nuclear fragmentation [10].The induction of apoptosis may
involve either extracellular triggering signals as tumor necrosis factor or endogenous signals
such as a cytochrome c (cyt C) release [11], followed by caspase-and endonuclease-activation
[12], resulting in the disassembly of nuclear chromatin and degradation of oligonucleosomal
DNA.
Several studies have identified other cell death programs clearly distinct from apoptosis [13],
and even if we know they are genetically regulated and often have morphological features
resembling necrosis, their underlying molecular mechanisms remain unclear. Autophagy is a
process that regulates the amount of cell death that occurs in response to specific stimuli like
blocking apoptosis after growth factor depletion [14-15] or external insults as DNA damaging
agents [16] protecting against caspase-independent death [17] and also by the action of a large
variety of anticancer drugs [18].
2. Casiopeínas, a new compound against cancer
Copper is an essential transition metal involved in diverse biological functions, quite especially
in redox balance processes [19]. Due to its properties, Copper and its complexes have the ability
to catalyze the generation of ROS by means of the Fenton reaction [20]. This process might
cause oxidative modification of cellular components like lipids, DNA and proteins, thus
disturbing the redox balance and interfering with the redox-related cellular signaling path‐
ways [21].
Casiopeínas is a family of new antineoplastic agents that have been synthesized, characterized
and patented in base of chelated Copper (II) complexes. Their general formula is [Cu(N–N)(a-
L-aminoacidate)]NO3 and [Cu(N–N)(O-O)]NO3, where the N–N donor is an aromatic substi‐
tuted diimine (1,10-phenanthroline or 2,20-bipyridine) and the O-O donor is acac or salal
(Figure 1). The underlying hypothesis is that nature, number and position of the substituents
on the diimine ligands, and modification of a-L-amino acidate or O–O donor will have an effect
either on the selectivity or on the degree of biological activity shown by the mixed ternary
Copper (II) complexes. Chemical data for Casiopeínas are: Cas IIgly [elemental analysis data:
calculated (%) for CuC16H16O5N4 2H20 (443.90 g/mol)]: C, 43.29; N, 12.62; H, 4.54. Found (%):
C, 43.59; N, 12.61; H, 4.52); Cas IIIia [(elemental analysis data: calculated (%) for
CuC17H19O5N3 2H20 (444.93 g/mol): C, 45.89; N, 9.44; H, 5.21. Found (%): C, 46.59; N, 9.80;
H 4.93)] and Cas IIIEa [(elemental analysis data: calculated (%) for CuC19-H19O5N3 H20
(450.94 g/mol): C, 50.61; N, 9.32; H, 4.69. Found (%): C, 51.37; N, 9.40; H 4.46)] [22].
Cas have been tested, both in vitro and in vivo, and have shown cytotoxic, genotoxic [23] and
antitumor activity [5, 24]. Cas have been shown good therapeutic indexes in human ovarian
carcinoma (CH1), murine leukemia (L1210), AS-30D rat hepatoma, cervix-uterine (HeLa),
breast, colon (HCT40) carcinomas, murine glioma C6, and human medulloblastoma (Daoy)
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and neuroblastoma (CHP-212 and SK-N-SH) cells [25-29]. As well as in animal tumor models
such isolated rat hearts [30], dogs [31-32], and nude mice models [5].
The precise mechanism of action for each Cas is still not completely understood and a detailed
description of the events that lead to cell death remains unexplained. However, there is evidence
that supports that these compounds are able to inhibit cell proliferation and produce cell death
by apoptosis by means of mechanisms dependent of caspases activation and independent of
caspases throughout ROS generation [24, 26, 29]. It has been shown that Cas are able to block
oxidative phosphorylation and to bind DNA by adenine and thymine interactions [33-35], and
computational modeling has been done in order to explain such an interaction [36-37]. This
suggests that there is more of than one biochemical action mechanism for Cas.
3. Apoptosis by means of Casiopeínas in neuroblastoma
According to previous research results of our group, neuroblastoma cell lines CHP-212 and
SK-N-SH have showed that Cas IIgly, IIIia and IIIEa, were active even at very low concentra‐
tions (8 μg/ml) when compared to cisplatin, their more efficient competing treatment [29].
These NB cells also showed a differential sensitivity for every Cas treatment and cell lineage
at 24 h. This last finding may be due a selectivity given for the specific ligands in the Copper
core. For instance, Cas IIgly and Cas IIIEa contain the same imine (4,7-dimethyl,1,10-phenan‐
throline) with a different charged ligand (glycine vs acetylacethonate). Then Cas IIIEa turned
out to be more active for CHP-212, whereas Cas IIgly is more active for SK-N-SH cell line.
Cellular origin of NB cell lines or even the lack of caspase-8 cleaved expression [38], are features
that may define the behavior of NB towards Cas.
Since caspase-8 is commonly silenced in NB, mitochondrial apoptosis is the preferential route
to apoptotic cell death, which may involve endogenous process such as cyt C release from
mitochondria, resulting in disruption of the mitochondrial transmembrane potential (Δψm)
[39]. This event generates a reduction in ATP levels with an influx of ions that leads to
decreased mitochondrial activity, and opening of the mitochondrial permeability transition
pores [40]. This is an essential component for caspase-3 activation [41].
Figure 1. Structures of Casiopeínas.(a) Cas IIgly [Cu (4,7-dimethyl-1,10-phenantroline) (glycinato) (H2O)] NO3; (b)
Cas IIIia [4,4’-dimethyl-2,2’-bipiridina) (acetylacetonato) (NO3)]. (c) Cas IIIEa [Cu (4,7-dimetyl-1,10-phenantroline) (ace‐
tylacetonato) (H2O)] NO3
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Under stress conditions such as those produced by Cas, the cell could promote several survival
Stimuli, one of them is expression of the Bcl-2 family of proteins. Even when Bcl-2 protein is
found in the cytoplasmic fraction of treated cells, its expression does not result enough to stop
the apoptotic process. In contrast, the expression of the well-known apoptosis promoter Bax
is decreased in neuroblastoma cells treated with Cas. Casiopeínas then possess several
mitochondrial targets in NB. The main effects of these is production of ROS that in turn provoke
Δψm loss, with an augmented Bcl-2 and cyt C release and a massive entrance of Bax protein.
By considering, all this body of evidence together we may support the position that the
apoptotic pathway favored by Casiopeínas in NB is the intrinsic route [29].
4. Autophagy and Copper compounds in neuroblastoma
Autophagy is a dynamic process that involves the arrest of cytoplasmic portions and intra‐
cellular organelles in large double-membrane vesicles (autophagosomes). When these vesicles
are fused with lysosomes they generate autophagolysosomes and mature lysosomes, where
the arrested material is degraded, inducing cell death [42-43].
Constitutive autophagy enables the physiologic turnover of intracellular components, thus
playing an important function in cell homeostasis. However, autophagy can be rapidly
induced as a defensive stress response [44-45]. Although apoptosis and autophagic cell death
present distinct morphological features among themselves, the two pathways overlap at the
level of various signaling steps and may converge and be integrated at the level of the same
organelles (i.e. the lysosome and the mitochondrion) [48].
Another molecule involved in the autophagic process is the cytoplasmic form of LC3-I, which
during the formation of autophagosomes is cleaved and liquefied to give rise to the membra‐
nous form LC3-II. The expression levels of LC3-II can be used to estimate the abundance of
autophagosomes before they are degraded by lysosomal hydrolases and the subcellular
localization of LC3 redistributes from a cytosolic diffuse pattern to punctuate staining in
vacuolar membranes when autophagy is induced. Increased autophagic activity is then
reflected by the enhanced conversion of LC3-I to LC3-II.
In a model of rat glioma C6 treated with Cas IIIia were found augmented levels of LC3,
particularly of LC3-II, leading to an increased ratio of LC3-II/LC3-I. These results indicate that
Cas IIIia induced autophagy promoters such as LC3-II and Beclin-1 [47]. When autophagy was
subsequently prevented with 3-methyladenine (3-MA), localization of LC3 at the autophago‐
somal membrane was inhibited and tumor cells were rescued from cell death [48]. Meanwhile,
when neuroblastoma cells (CHP-212) were treated with Cas IIgly, Cas IIIia, Cas IIIEa and
cisplatin, LC3-II increases protein at 2 h and 10 h were observed. However at 24 h this molecule
was absent, indicating that there was another event different to cellular death [50].
Beclin-1 is a clue regulator of autophagy that directly interacts with Bcl-2, because when they
are bound, Beclin-1 is incapable of activating autophagy. However, autophagy is induced by
the release of Beclin-1 from Bcl-2 by pro-apoptotic BH3 proteins, Beclin-1 phosphorylation by
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DAP kinase (DAPK), or Bcl-2 phosphorylation by JNK [50-51]. Conversely, over-expression of
Bcl-2 or Bcl-XL can inhibit autophagy [52-54]. Another Beclin-1-dependent mechanism by
which apoptosis can inhibit autophagy is through caspase-3 cleavage of Beclin-1 to produce a
truncated protein that is unable to promote autophagy, thus leading to the overall inhibition
of autophagy [55].
Depending of the status of caspase-3, neuroblastoma cells may switch between autophagic and
apoptotic cell death. It was found that a targeted toxin kills glioma cells via a caspase-inde‐
pendent mechanism, and when autophagy is inhibited, this increases (modestly) the amount
of death, but changes dramatically the mode of death by allowing the toxin to activate caspases.
These data show that autophagy can alter the way cells die, not just whether they die or not [56].
Autophagy in cells treated with Casiopeínas may be result of a diminished effect of this
compound that on low doses may not be efficient enough to produce apoptosis. Thus,
caspase-3 activity was found in neuroblastoma cells, yet at very early times (2 and 4 h); whilst
at 24 h this protein was totally absent [29]. This event is probably seemed to point out that low
doses of Cas treatments enable the physiologic turnover of the tumoral cells. In a model of C6
rat glioma cells treated with low doses (5-10 μg/ml) of Casiopeína IIIia, effects at 24 h were
also compatible with autophagic features [32].
5. The role of ROS in apoptosis and autophagy in NB
Among several effector mechanisms are involved in the control and regulation of cell death
pathways, including autophagy and apoptosis, it seems that the starting point is related with
changes in the cellular redox status. In the cell, this stage is determined by the balance between
rates of production and breakdown of ROS, including free radicals such as superoxide,
hydroxyl radical and non-radicals capable of to generate free radicals (i.e., H2O2) [57 ].
A deeper understanding of the mechanisms linking the oxide-radicals-induced autophagy
response to cell death pathways, may suggest new therapeutic strategies for the treatment of
oxidative stress-associated diseases and phenotypic conditions. For instance, apoptosis
observed with Cas treatments, might be the result of one or several events which lead to this
final effect: these signals could be mediated by generation of ROS [23-24, 29], by mitochondrial
toxicity [58], or both, and might play –either alone or cooperatively- an important role in the
regulation of cell death induced by this type of complexes. Several studies have shown that
inhibition of cell proliferation and DNA degradation [59-60]) in the presence of reducing agents
is simultaneous to ROS generation, suggesting that DNA oxidation observed on cells might
also be triggering cell death.
Exposure of C6 glioma cells to Cas IIIia resulted in cell death, with structural and biochemical
features consistent with autophagy and apoptosis. Furthermore, the involvement of ROS
generation and JNK activation, were showed to be the main features of the autophagic and
apoptotic pathways [47]. Hydrogen peroxide reacts with the superoxide radical to constitute
itself into a non-radical reactive species. Even toughH2O2 is less reactive than radical oxygen
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it can produce higher levels of cellular damage. Since it hydrolyzes metals -specially iron Fe(II)
and Copper Cu(I)- giving rise to Fenton reactions, a phenomenon already documented in Cas-
therapy [6, 58].
On the other hand, it has been reported that low H2O2 concentrations (as low as 100μM), are
able to induce several events including morphological cell changes, DNA fragmentation and
caspase-activation in leukemia cell lines [61]. For this reason H2O2 increase by Cas treatment
might be implied, either in apoptosis induction or participating as a substrate in Fenton’s
reaction, producing hydroxyl radical which is a highly reactive and affecting different
biomolecules, which not only may cause an apoptotic process but also secondary necrosis. ROS
increase could then promote p53-mediated increase of both Bax messenger and protein,
implicating cyt C release and consequently promoting caspase-3 activation [62]. In neuroblas‐
toma cells, Cas treatments can induce ROS expression that in turn is related with mitochondrial
apoptosis [29].
Superoxide radical is produced when molecular oxygen accepts an electron which remains
unpaired. Within the cell this process takes place mainly in the mitochondria, since as a
consequence of metabolism, oxygen receive transported electrons [63]. Superoxide synthesis
is increased by the influence of factors as radiation or chemicals like pharmaceutical drugs and
narcotics. Treatment by Cas increase the concentrations of superoxide thus promoting an
unusually high oxidizing environment. This highly oxidant environment cannot be regulated
by means of the usual antioxidant defense mechanisms of the cell [6, 23]. For this reason
oxidative stress appears, thus damages biomolecules, in particular mitochondrial DNA [58].
As a consequence, cells die via the intrinsic route to apoptosis [29, 49]
Previous findings suggest that Copper–phenanthroline complexes react in a redox-cycle with
thiols and H2O2, resulting in ROS production [64]. On the other hand, glutathione (GSH)
indexes haves been related directly to apoptosis due to the ROS expression. In order to
maintain the basal concentrations of GSH in the cell, glutathione reductase (Grd) reduces GSS
to GSH [65]. Intracellular GSH decrement is thus related to ROS production, because the
sulphydril group of Cas is charged in order to trap reactive species that forms a coordinated
covalent link with the metal, thus reducing GSH to GSS, by means of a nucleophilic substitution
reaction. Platinum is, in the other hand, a soft metal which has affinity to soft donors like those
in glutathione’s cysteine group. This link may be the mechanism by which the cells eliminate
cisplatin. Such processes are implied in producing the low levels of GSH detected in both cell
lines after cisplatin treatment, since elimination of cisplatin related to GSS avoids Grd regen‐
eration of the basal levels of GSH. This effect has been reported in several neoplasic lines after
the treatment with cisplatin [6, 58].
In fact, Copper has been reported as reacting with GSH to form a stable complex [58]. Never‐
theless, it is not clear if this is the elimination mechanism for Cas, or if this complex interferes
with the process of GSH regeneration. Decrease in intracellular levels of GSH has been reported
in murine melanoma and pulmonary cancer cells treated with Cas IIgly, since Cas catalyzes
Fenton’s reaction and GSH acts catching the produced ROS [6, 29, 58]. These results allow us
to explain the decreased intracellular levels of GSH resulting after treatment with Cas. This
comes as a result of a pro-oxidant atmosphere, which could be produced since Fenton’s
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reaction is catalyzed through the active Copper core in Casiopeínas. Our results support the
hypothesis that, under certain conditions, GSH can be a substrate for pro-oxidant reactions in
the cell. CasII gly has been previously shown to interfere directly with the mitochondrial
respiratory chain, another effect that could account for an increase in ROS [66]. However, both,
delayed ROS burst and mitochondrial depolarization observed by flow cytometry, support
Cas IIgly-mediated indirect effects, i.e. GSH depletion and disruption of the mitochondrial
respiratory chain due to mitochondrial DNA damage. Given the fast drop in GSH levels, such
delay may be due to the ability of the cells to initially control ROS levels, including O2-● and
HO●; however, after some time this ability results exhausted.
The activation of either the pro-survival or the pro-death pathways by oxidative stress depends
on the type of ROS and the site of its generation [65, 67], the dose and length of exposure, as
well as on the genetic and metabolic background of the target cell [68-73]. Understanding the
mechanisms linking the oxide-radicals-induced autophagy response to cell death pathways
could suggest new therapeutic strategies for the treatment of neuroblastoma.
6. Pathways and biological processes
As we have seen the action mechanisms of Cas-based chemotherapeutics involves system-level
interactions of a number of biochemical processes in the cell, including apoptosis, autophagy,
and response to oxidative stress as main motifs; but also involving (to some extent) signaling
pathways such as NGF, SCF-KIT, interleukins, and FGFR. Immune response processes
involving interferon (alpha/beta), PI3K/AKT; as well as B-cell activation and phosphorylation
cascades. With so many complex processes interacting one may wonder what the driving
forces (and what the ‘side-effects’) are.
In order to acquire a closer understanding of these processes, we performed computational
and data-mining analyses in both protein-protein interactions and biochemical pathway
enrichment. Particular emphasis has been paid to molecular interactions related with the turn-
over between apoptosis and autophagy since these are the main mechanisms of cell death
observed in NB cells after Cas treatment.
6.1. Protein interaction networks
Computational mining in protein-protein interaction databases (String) was performed in a
curated list of molecules associated with apoptosis. The results may be seen in Figure 2. Panel
A presents the associated protein-protein (physical) interaction network. Panel B renders a
visualization of the same network color- and size-coded according with their connectivity
degree: big red circles represent protein that are highly connected within such network (i.e.
proteins that may interact in a large number of macromolecular assemblies and other func‐
tional roles) while small green nodes are less connected proteins.
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Figure 2. Protein interaction network of apoptotic molecules Panel A displays the protein-protein (physical) inter‐
action network for molecules playing a role in apoptotic processes. Panel B renders a visualization of the same net‐
work color- and size-coded according with their number of known interactions. Big, red circles are thus highly
interacting apoptotic molecules.
One may hypothesize that highly connected proteins (or hubs) perform central roles in their
corresponding biochemical pathways [73]. In fact, by considering the hubs in Figure 2 B we
may see this. Molecules such as TP53, TNF, BCL2, NFKB1, BAX, MAPK8, BCL2L1, CASP3,
APAF1, FAS, TRAF2, STAT1, TNFRSF1A, MYC, STAT3, RELA, and CASP8 seem to be the
main players in the pro-apoptotic/anti-apoptotic molecular switching. These general trends
may vary from one tissue/phenotype to another (for instance CASP8 is usually absent or mildly
expressed in NB cells) yet their compact interaction structure allows for biological robustness,
as displayed for instance in the complementary roles of intrinsic and extrinsic apoptosis.
A similar analysis was performed for molecules associated with autophagy; in Figure 3 we can
see the protein interaction network for these molecules. Again panel A shows the protein-
protein network. Panel B also displays the network color- and size-coded according with the
individual connectivity degree. The key players in this process seem to be MTOR, TP53,
UBA52, BCL2, BECN1, AKT1, FAM48 A, and to a lesser extent PTEN, ULK1, PIK3C3, ATG5,
HSP90AA1 and JUN. Interestingly enough this network is not so densely connected as the one
corresponding to apoptosis (Figure 2) a fact that may result in important outcomes: the
network is less robust to removal of one of its key players hence the regulatory mechanisms
should be more strict. This may be a reason for apoptosis (and not autophagy) as the main
mechanism of cell death.
Given the fact that treatment by Casiopeínas in NB may involve a turn-over between apoptotic
and autophagic cell death, it results appealing to analyze the protein interaction network of
molecules common to both processes since these molecules may serve as switches between
both regimes. In Figure 4 we can see the depiction of a (much simpler) protein interaction
network involving molecules related both to apoptosis and autophagy: main players in both
processes are BCL2, TP53, and AKT1 with TNFSF10, TRAF6, BNIP3 and BECN1 also associ‐
ated. Again, response to oxidative stress, DNA damage and cell signaling are represented in
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this set. Especially intriguing results the role of AKT1 since it is known that some survival
factors, induce transcription-independent anti-apoptotic behavior by activation of the onco‐
gene-homolog RAC. AKT1 in turn, phosphorylates inactivating components of the apoptotic
machinery.
Figure 4. Protein interaction network of molecules involved both in apoptotic and autophagic pathways Mole‐
cules are again size and color-coded according with the number of interactions. The role of BCL2, TP53 and AKT1 as
strongly interacting molecules centrally-involved both in apoptosis and autophagy may point to these molecules as
concertators for the transition between these processes.
Figure 3. Protein interaction network of autophagic molecules Panel A displays the protein-protein (physical) in‐
teraction network for molecules playing a role in authphagy. Panel B renders a visualization of the same network col‐
or- and size-coded according with their number of known interactions. Big, red circles are highly interacting
autophagic molecules.
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6.2. Coupled biochemical pathways
After considering physical interactions between proteins related both to apoptosis and
autophagy, we may wonder which are the most common cellular processes involving such
molecules. Resorting to data-mining and enrichment analyses in the REACTOME database we
found the following pathways (see Fig.4).
7. Conclusions
In the search for new keys to undermine neuroblastoma, our knowledge of the pathways
limiting tumor growth, as well as a deeper understanding of the molecules involved in these
processes result essential. Based on years of research, our experience is that chemotherapeutic
interventions based in Copper compounds as an essential metal, have opened new possibilities
to understand not only the pharmacology but indeed some of the biology behind neuroblas‐
toma's behavior. In this sense, we consider of extreme importance to understand, for instance,
how Casiopeínas affect neuroblastoma cells in such a way that they finally undergo cellular
death by apoptosis, or either -in what resembles a failed attempt of cellular rescue- resort to
autophagy. By identifying key molecules for these processes by means of functional genomics
and similar analyses we may be able to determine if there are other routes involved in
neuroblastoma's final-fate decision processes.
With regards to apoptosis associated molecules, these also take part in biological functions
such as: NGF-signaling (TRIB3, MAPK7, RAF1, PRKAR1A, MDM2, BCL2L11, DUSP6,
NFKBIA, NGFR, RIPK2, BRAF, NGFRAP1, MYD88, MAPK8, NFKB1, AKT1, PIK3R1, CASP9,
CHUK, GSK3B, SRC, CASP2, MLLT7, AKT3, FOXO1A, STAT3, FOXO3A, MAGED1, TRAF6,
MAPK1, BAD, CDKN1A, RELA, CASP3, HRAS, NTRK1, AATF, YWHAE, NGFB, GRB2),
Interleukin-signaling (IL6ST, IL18, STAT5A, RAF1, IL3, CARD15, CSF2RB, HRAS, RIPK2,
MYD88, STAT5B, NFKB1, STAT1, PIK3R1, CARD4, CHUK, IL1A, JAK1, IL2RG, IL6, STAT3,
CASP1, TRAF6, IL1R1, MAPK1, GRB2, IL7), SCF-KIT signaling (BAD, TRIB3, CDKN1A,
STAT5A, RAF1, MDM2, HRAS, STAT5B, AKT1, STAT1, PIK3R1, CASP9, CHUK, GSK3B,
SRC, MLLT7, FOXO1A, AKT3, STAT3, FOXO3A, MAPK1, GRB2) and activation of BAD and
translocation to the mitochondria (BAD, AKT1, BCL2, BID); amongst others (full enrichment
analysis –more than 500 statistically significant (p<0.05) processes- available upon request).
In the case of autophagic molecules, they also participate in the following biological processes:
PI3K/AKT activation (PTEN, PDK1, Lst8, FoxO3, PKB, FoxO1, MTOR), adaptive immune
system (TAK1, ATG5, LRSAM1, BCL2, ATG7, ATG12, PKR, Rab7, PDK1, FoxO1, CD46,
HMGB1, PTEN, RAGE, JNK1, FoxO3, Lst8, Vps34, PKB, TRAF6, MTOR), as well as in the
regulation of apoptosis (JNK1, BCL2, ZIPK, PKB, TRAIL, HMGB1, DAPK) by activation of
BAD and translocation to mitochondria (BCL2, PKB) also among many others [full enrichment
analysis of more than 200 statistically significant (p<0.05) pathways available upon request].
One interesting case for study in the analysis of apoptotic and autophagic pathways as an effect
of Cas therapy, is the biochemical processes (other than apoptosis and autophagy) involving
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apoptotic/autophagic molecules, these involve autodegradation of the E3 ubiquitin ligase
COP1 (ATM, TP53) related to DNA damage repair, NOD-like receptor signaling (BCL2,
TRAF6) closely associated with inflammatory processes, and immune system preparation
(AKT1, BCL2, SUMO1, TRAF6, ATG5). In all the biological response of NB to treatment with
Cas seem to involve oxidative stress causing immune response, cytokine inflammation and
DNA damage leading to cell death initiation either by apoptosis or autophagy depending on
the specific kinase signaling present.
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